Octyl triazone inclusion in sunscreen monograph based on foreign use data sought by BASF.
OCTYL TRIAZONE INCLUSION IN SUNSCREEN MONOGRAPH SOUGHT BY BASF AG as a Category I (generally recognized as safe and effective) sunscreen ingredient on the basis of its foreign marketing experience. In a Nov. 15 petition filed by the D.C. law office of Morgan, Lewis & Bockius, the German firm BASF asks FDA to reopen the administrative record of the OTC Sunscreen Drug Products Review to include octyl triazone, which BASF sells overseas under the trade name Uvinul T 150. The ingredient was approved in the EU member countries in 1989 and in Japan this March.
More from Archive
More from Pink Sheet
The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.